Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Exercise test predicts heart events in high risk asymptomatic men

28.09.2004


Among men without heart disease but who have significant cardiac risk factors, a poor performance on an exercise treadmill test is associated with more than doubling of the risk for a heart attack or other coronary heart disease event, according to a report in Circulation: Journal of the American Heart Association.



Exercise treadmill testing is not generally recommended as routine screening for people with no history or symptoms of heart disease. This is the first study to evaluate exercise testing among asymptomatic people relative to their predicted coronary heart disease (CHD) risk using the Framingham risk score.

The Framingham Risk Score assigns point values to risk factors such as high blood pressure, total cholesterol, HDL cholesterol, age, diabetes and smoking history to predict the risk of an event such as chest pain, heart attack or coronary death over a 10-year period. A risk score of 9 percent or less is considered low risk, 10 percent to 19 percent is considered intermediate risk, while a score of more than 20 percent, meaning that the person has a one in five chance of an event in 10 years, is classified as high risk. "Our results suggest that exercise testing may be of benefit in asymptomatic men with intermediate to high risk," said Gary J. Balady, M.D., a professor of medicine at Boston University School of Medicine and an investigator with the Framingham Heart Study.


He and colleagues found that a change in electrocardiogram (ECG) tracing called ST-segment depression or failure to reach target heart rate during exercise testing more than doubled the 10-year risk of coronary event in men with high Framingham risk, compared to those who did not have these findings on the stress test.

But increased exercise capacity predicted lower CHD risk in the high-risk men. "Greater exercise tolerance as measured in metabolic equivalents (METS) had a lower 10 year event rate," he said. Each MET increase, which is a multiple of the resting metabolic rate, was associated with a 13 percent decrease in risk of coronary event.

The study did not provide evidence to support exercise testing for asymptomatic women because the event rate in women was too low to suggest any significant correlations between the exercise results and future events, he said.

All study participants were asymptomatic at baseline. The study included 1,431 male and 1,612 female Framingham Heart Study participants. Their average age at baseline was 45 and the participants were followed for more than 18 years. During follow-up, 224 men (15.7 percent) developed a coronary event such as chest pain, heart attack or died from CHD.

Balady said that high-risk men who have ST-segment depression or fail to achieve target heart rate on the exercise treadmill test "should get maximum risk reduction. That means aggressive blood pressure and lipid control, and of course, we want everyone to stop smoking." Also, among these patients it would be prudent to consider additional diagnostic tests to determine the extent of disease, which may include imaging stress tests or invasive procedures such as angiography to assess the condition of arteries and locate any blocked or narrowed vessels.

However, he said it is important to note that this study did not find that exercise testing provided additional prognostic information in those with 10-year-CHD risk less than 10 percent. The authors conclude that clinicians should consider the global cardiac risk, using the Framingham Risk Score, prior to ordering an exercise tolerance test in asymptomatic men without known heart disease.

Carole Bullock | EurekAlert!
Further information:
http://www.heart.org

More articles from Health and Medicine:

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

nachricht A new approach to high insulin levels
18.09.2017 | Schweizerischer Nationalfonds SNF

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>